CAS: 28380-24-7; Nigericin

该化合物是某种抗生素的聚醚,由某些物种的发酵而产生,特别是血栓菌,特别是血栓菌的血压和血压,其特点是能够将钾离子迁移到生物膜中,从而破坏细胞细胞离子的软骨保持.这种离子素具有独特的结构,包括一个大型环状环状环,能够形成含有细胞综合体,特别是K+和Na+. 尼氏素以其抗微生物特性而著称,并研究其在研究和医学中的潜在应用,特别是在细胞生物学和药理学方面.它可以通过改变电离子梯度影响各种细胞过程,包括线粒体功能和吸附性.此外,尼古林在涉及离子传输装置和细胞信号路径的研究中被利用,但其使用往往有限,原因是潜在的毒性和实验室环境中需要谨慎处理.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号138285-65-1 1,30-Dddn

合成工艺路线路线简述

    Nigericin Sodium Salt置于高氯酸体系中,用 氯仿 用作溶剂,化学反应 1.0H,反应生成尼日利亚菌素
    参考文献: Ligand Ionophore Conjugates[fr] Conjugués Ligand-Ionophore
    标题: Ligand Ionophore Conjugates[fr] Conjugués Ligand-Ionophore
    摘要:本发明涉及配体-离子载体共轭物,可能还包括连接的治疗剂或成像剂,并含有该共轭物的药物组合物.还描述了使用这些共轭物来增加治疗剂或成像剂在内体器的积累和逃逸的方法.

    海关参考信息

    专利信息


    专利号:US-5905091-A
    优先权日:1996-07-03
    标 题 :Enhancement of skin pigmentation by prostaglandins
    发明人:FULLER BRYAN B
    权利人:UNIV OKLAHOMA
    摘要:A composition comprising a carrier and prostaglandin effective in stimulating synthesis of melanin in a human melanocyte thereby enhancing pigmentation of the human skin and optionally comprising a lysosomotropic agent, a phosphodiesterase inhibitor, and/or methylxanthines, and a method of use of the composition. Use of this composition promotes tanning of the human skin and increases photoprotection from ultraviolet radiation.

    专利号:WO-2018005963-A1
    优先权日:2016-07-01
    标 题:Synthesis of new methylumbelliferone prodrugs and their incorporation into lipid-based drug delivery formulations
    发明人:SZOKA FRANCIS C JR; DAI ZHIPENG
    权利人:ZONEONE PHARMA INC
    摘要:Lipophilic prodrugs of 4-methylumbelliferone are incorporated into lipid based drug delivery systems (e.g., emulsions, micelles, liposomes and lipid particles). The formulations protect 4-methylumbelliferone from first pass hepatic metabolism to 4-MUG. Exemplary formulations are oral and parenteral formulations. Methods of treating proliferative diseases, e.g., cancer by administering the formulation to a subject in need thereof are provided.

    专利号:US-12018305-B2
    优先权日:2018-12-10
    标题:Process for production of nigericin from Streptomyces sp. MCC-0151
    发明人:SYED GULAM DASTAGER; SAHU AMIT KUMAR
    权利人:COUNCIL SCIENT IND RES
    摘要:A fermentation process is provided for the synthesis of Nigericin from Streptomyces sp. having accession number MCC 0151 and its isolation with high yield. A microbial inoculant composition is provided, comprising a biologically pure culture of Streptomyces sp. MCC 0151 for the exclusive production of Nigericin with high yield.

    专利号:US-12428442-B2
    优先权日:2017-06-21
    标题 :Compounds, compositions and methods for synthesis
    发明人:BUTLER DAVID CHARLES DONNELL; HENCKEN CHRISTOPHER P; IWAMOTO NAOKI; KANDASAMY PACHAMUTHU; LANAO ALVARO ANDRES; LU GENLIANG; SHIMIZU MAMORU; DIVAKARAMENON SETHUMADHAVAN; VARGEESE CHANDRA; BOMMINENI GOPAL REDDY; MARAPPAN SUBRAMANIAN
    权利人:WAVE LIFE SCIENCES LTD
    摘要:The present disclosure, among other things, provides technologies for synthesis, including reagents and methods for stereoselective synthesis. In some embodiments, the present disclosure provides compounds useful as chiral auxiliaries. In some embodiments, the present disclosure provides reagents and methods for oligonucleotide synthesis. In some embodiments, the present disclosure provides reagents and methods for chirally controlled preparation of oligonucleotides. In some embodiments, technologies of the present disclosure are particularly useful for constructing challenging internucleotidic linkages, providing high yields and stereoselectivity.

    专利号:US-8648035-B2
    优先权日:2007-08-17
    标题 :Identification and use of peptide inhibitors of protein synthesis
    发明人:LLANO-SOTELO BEATRIZ; MANKIN ALEXANDER S; KLEPACKI DOROTA
    权利人:LLANO-SOTELO BEATRIZ; MANKIN ALEXANDER S; KLEPACKI DOROTA; UNIV ILLINOIS
    摘要:The present invention discloses compositions of peptide inhibitors of protein synthesis, and methods of identifying peptide inhibitors that are capable of inhibiting protein synthesis through an interaction at a stem-loop H18 in 16S rRNA of a 30S ribosomal subunit. Screening methods for peptides are disclosed, in addition to methods of determining the affinity of a test compound for a ribosomal subunit.

    专利号:US-9217150-B2
    优先权日:2008-03-20
    标题 :NRPS-PKS gene cluster and its manipulation and utility
    发明人:JØRGENSEN HANNE; ELLINGSEN TROND ERLING; DEGNES KRISTIN FLØGSTAD; BRUHEIM PER; SLETTA HÃ…VARD; FJAERVIK ESPEN; KLINKENBERG GEIR; ZOTCHEV SERGEY
    权利人:JØRGENSEN HANNE; ELLINGSEN TROND ERLING; DEGNES KRISTIN FLØGSTAD; BRUHEIM PER; SLETTA HÃ…VARD; FJAERVIK ESPEN; KLINKENBERG GEIR; ZOTCHEV SERGEY; SINTEF TTO AS
    摘要:The present invention provides a nucleic acid molecule comprising: (a) a nucleotide sequence as shown in SEQ ID No. 1; or (b) a nucleotide sequence which is the complement of SEQ ID No. 1; or (c) a nucleotide sequence which is degenerate with SEQ ID No. 1; or (d) a nucleotide sequence having at least 85% sequence identity (preferably at least 87%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% sequence identity) with SEQ ID No. 1; or (e) a part of any one of (a) to (d), wherein said nucleic acid molecule encodes or is a complementary to a nucleic acid molecule encoding one or more polypeptides, or comprises or is complementary to a nucleic acid molecule comprising one or more genetic elements, having functional activity in the synthesis of a polyketide-based or macrolactam molecule. Particularly the invention contemplates the modification of the nucleic acid of the invention, encoding the biosynthetic machinery for the synthesis of the polyketide macrolactam BE-14106, including expressing in a microorganism the modified nucleic acid molecule. In certain aspects the modification includes introducing, mutating, deleting, replacing or inactivating a sequence encoding one or more activities or proteins encoded by said nucleic acid molecule. Other aspects of the invention include a microorganism containing the modified and unmodified nucleic acid and recovering the polyketide-based or macrolactam molecule from said microorganism.
    福建科瑞药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fjim.org.cn/
    电话: (0591)83470739👤
    📞福建科瑞药业有限公司 ⚠️参考联系方式

    销售电话:(0591)83470739
    邮箱:Lihua.Xiao@kerui.microport.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Gao G, Liu F, Xu Z, Wan D, Han Y, Kuang Y, Wang Q, Zhi Q. Evidence of nigericin as a potential therapeutic candidate for cancers: A review. Biomed Pharmacother. 2021 May;137:111262. doi: 10.1016/j.biopha.2021.111262. Epub 2021 Jan 25.
    134:108616. doi: 10.1016/j.fsi.2023.108616. Epub 2023 Feb 15.
    198:114938. doi: 10.1016/j.bcp.2022.114938. Epub 2022 Jan 31.

    合成参考文献


    摘要:Antibiotics and Chemotherapy, 1(594), 1951
    摘要:CRC Handbook of Antibiotic Compounds, Vols.1- , Berdy, J., Boca Raton, FL, CRC Press, 1980, 5(477), 1981
    参考文献:10.1021/bi00547a031
    摘要:Rebois RV, Reynolds EE, Toll L, Howard BD. Storage of dopamine and acetylcholine in granules of PC12, a clonal pheochromocytoma cell line. Biochemistry. 1980 Mar 18;19(6):1240–8. doi: 10.1021/bi00547a031.
    参考文献:10.7164/antibiotics.33.94
    摘要:Tsuji N, Terui Y, Nagashima K, Tori K, Johnson LF. New polyether antibiotics, A-130B and A-130C. J Antibiot (Tokyo). 1980 Jan;33(1):94–7. doi: 10.7164/antibiotics.33.94.
    参考文献:10.1128/jb.142.1.295-301.1980
    摘要:Apel WA, Dugan PR, Tuttle JH. Adenosine 5'-triphosphate formation in Thiobacillus ferrooxidans vesicles by H+ ion gradients comparable to those of environmental conditions. J Bacteriol. 1980 Apr;142(1):295–301. doi: 10.1128/jb.142.1.295-301.1980.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知